InnovAge Holding Corp. Financial Ratios
INNV / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-12.9%
Profit Margin
-3.6%
Net Income / Revenue
Asset Turnover
1.62
Revenue / Total Assets
Equity Multiplier
2.24
Total Assets / Equity
Composite: -12.9% (reported: -12.9%)
Profitability
Liquidity
Current Ratio
1.07
Quick Ratio
1.07
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
1.62
Inventory Turnover
-
Days Sales Outstanding
16 days
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-11.8%
-14.6pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.